Quadrant Capital Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$557K Buy
8,623
+427
+5% +$30.1K 0.02% 859
2025
Q4
$552K Sell
8,196
-309
-4% -$20.8K 0.02% 868
2025
Q3
$624K Buy
8,505
+293
+4% +$19.5K 0.02% 752
2025
Q2
$427K Sell
8,212
-654
-7% -$37.2K 0.02% 969
2025
Q1
$566K Buy
8,866
+7,188
+428% +$418K 0.02% 659
2024
Q4
$80.2K Sell
1,678
-146
-8% -$7.49K 0.01% 1174
2024
Q3
$104K Buy
1,824
+85
+5% +$4.87K 0.01% 1044
2024
Q2
$91.1K Hold
1,739
0.01% 1067
2024
Q1
$70.7K Sell
1,739
-1,675
-49% -$62.8K 0.01% 1183
2023
Q4
$126K Buy
3,414
+624
+22% +$23.5K 0.01% 856
2023
Q3
$107K Buy
2,790
+122
+5% +$5K 0.01% 832
2023
Q2
$96.2K Buy
2,668
+1,634
+158% +$55.8K 0.01% 899
2023
Q1
$39.5K Buy
1,034
+74
+8% +$3.47K ﹤0.01% 1368
2022
Q4
$54.6K Buy
960
+506
+111% +$25.9K 0.01% 1118
2022
Q3
$18K Buy
454
+2
+0.4% +$88 ﹤0.01% 1605
2022
Q2
$20K Buy
452
+93
+26% +$4.02K ﹤0.01% 1306
2022
Q1
$14K Buy
359
+129
+56% +$4.59K ﹤0.01% 1495
2021
Q4
$9K Buy
230
+73
+46% +$2.73K ﹤0.01% 1667
2021
Q3
$6K Buy
157
+33
+27% +$1.38K ﹤0.01% 1800
2021
Q2
$6K Buy
124
+3
+2% +$133 ﹤0.01% 1774
2021
Q1
$5K Buy
121
+13
+12% +$593 ﹤0.01% 1775
2020
Q4
$5K Hold
108
﹤0.01% 1690
2020
Q3
$3K Buy
108
+14
+15% +$390 ﹤0.01% 1714
2020
Q2
$3K Sell
94
-1,959
-95% -$44.2K ﹤0.01% 1802
2020
Q1
$36K Buy
2,053
+11
+0.5% +$209 0.01% 1023
2019
Q4
$35K Buy
+2,042
New +$35.4K ﹤0.01% 1497
2016
Q1
Sell
-354
Closed -$6K 1873
2015
Q4
$6K Buy
+354
New +$5.64K ﹤0.01% 983

Other funds holding HALO

Quadrant Capital Group's HALO Position: Q1 2026 in Review

Quadrant Capital Group increased its Halozyme (HALO) stake by 5.2% in Q1 2026, buying an estimated $30.1K and bringing the position to 8,623 shares worth $557K. The position accounts for 0.02% of the portfolio, ranked #859.

Quadrant Capital Group first reported a position in HALO in Q4 2015 and has held it in 27 quarters since. The position peaked at $624K in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Quadrant Capital Group held 8,623 shares of Halozyme worth $557K as of Q1 2026.
  • Quadrant Capital Group bought 427 Halozyme shares in Q1 2026, an estimated $30.1K.
  • Halozyme made up 0.02% of Quadrant Capital Group's portfolio in Q1 2026, its #859 holding.
  • Quadrant Capital Group first reported a position in Halozyme in Q4 2015 and has held it in 27 quarters since.
  • Quadrant Capital Group's Halozyme position peaked at $624K in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.